94 related articles for article (PubMed ID: 10675753)
21. Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer.
Ausch C; Dandachi N; Buxhofer-Ausch V; Balic M; Huber K; Bauernhofer T; Ogris E; Hinterberger W; Braun S; Schiessel R
Clin Chem Lab Med; 2007; 45(3):351-6. PubMed ID: 17378731
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells.
Smeland EB; Funderud S; Kvalheim G; Gaudernack G; Rasmussen AM; Rusten L; Wang MY; Tindle RW; Blomhoff HK; Egeland T
Leukemia; 1992 Aug; 6(8):845-52. PubMed ID: 1379314
[TBL] [Abstract][Full Text] [Related]
23. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
25. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
26. Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
Motta MR; Castellani S; Rizzi S; Curti A; Gubinelli F; Fogli M; Ferri E; Cellini C; Baccarani M; Lemoli RM
Br J Haematol; 2003 Apr; 121(2):240-50. PubMed ID: 12694245
[TBL] [Abstract][Full Text] [Related]
27. Isolation of large and pure samples of human erythroid precursors at different stages of maturation using immunomagnetic separation of cells from liquid cultures.
Vaisman B; Konijn AM; Fibach E
Acta Haematol; 1999; 101(3):135-9. PubMed ID: 10352332
[TBL] [Abstract][Full Text] [Related]
28. MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.
Fujii R; Ishikawa H; Mahmoud MS; Asaoku H; Kawano MM
Br J Haematol; 1999 Apr; 105(1):131-40. PubMed ID: 10233376
[TBL] [Abstract][Full Text] [Related]
29. Establishment of cell lines from both myeloma bone marrow and plasmacytoma: SNU_MM1393_BM and SNU_MM1393_SC from a single patient.
Koh Y; Jung WJ; Ahn KS; Yoon SS
Biomed Res Int; 2014; 2014():510408. PubMed ID: 25343143
[TBL] [Abstract][Full Text] [Related]
30. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.
Rawstron AC; Davies FE; Owen RG; English A; Pratt G; Child JA; Jack AS; Morgan GJ
Br J Haematol; 1998 Jan; 100(1):176-83. PubMed ID: 9450807
[TBL] [Abstract][Full Text] [Related]
31. Isolation and culture of human bone marrow endothelial cells.
Schweitzer CM; van der Schoot CE; Dräger AM; van der Valk P; Zevenbergen A; Hooibrink B; Westra AH; Langenhuijsen MM
Exp Hematol; 1995 Jan; 23(1):41-8. PubMed ID: 7995370
[TBL] [Abstract][Full Text] [Related]
32. The isolation and identification of murine dendritic cell populations from lymphoid tissues and their production in culture.
Vremec D; Shortman K
Methods Mol Biol; 2008; 415():163-78. PubMed ID: 18370154
[TBL] [Abstract][Full Text] [Related]
33. Galectin-1 supports the survival of CD45RA(-) primary myeloma cells in vitro.
Abroun S; Otsuyama K; Shamsasenjan K; Islam A; Amin J; Iqbal MS; Gondo T; Asaoku H; Kawano MM
Br J Haematol; 2008 Sep; 142(5):754-65. PubMed ID: 18537967
[TBL] [Abstract][Full Text] [Related]
34. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting.
Wang GY; Li Y; Yu YM; Yu B; Zhang ZY; Liu Y; Wang SJ
J Gastroenterol Hepatol; 2009 Feb; 24(2):299-306. PubMed ID: 19032456
[TBL] [Abstract][Full Text] [Related]
35. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.
Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G
J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439
[TBL] [Abstract][Full Text] [Related]
36. More mesenchymal stem cells enriched from bone marrow aspirates by culturing bone marrow particles and mononuclear cells separately.
Xing W; Liu PX; Liu M; Yang SG; Zhao QJ; Li JP; Lu SH; Ren HY; Huang Y; Wu H; Liu B; Zhang L; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1552-9. PubMed ID: 21176369
[TBL] [Abstract][Full Text] [Related]
37. [Biological properties of mesenchymal stem cells derived from bone marrow of patients with multiple myeloma].
Zhu BD; Ren J; Wang XY; Li X; Nie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1138-42. PubMed ID: 17204180
[TBL] [Abstract][Full Text] [Related]
38. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
[TBL] [Abstract][Full Text] [Related]
39. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
[TBL] [Abstract][Full Text] [Related]
40. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID
Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
